FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer

Qipeng Fan, Qingchun Cai, Yan Xu

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Lysophosphatidic acid (LPA), a prototypical ligand for G protein coupled receptors, and Forkhead box protein M1 (FOXM1), a transcription factor that regulates expression of a wide array of genes involved in cancer initiation and progression, are two important oncogenic signaling molecules in human epithelial ovarian cancers (EOC). We conducted in vitro mechanistic studies using pharmacological inhibitors, genetic forms of the signaling molecules, and RNAi-mediated gene knock-down to uncover the molecular mechanisms of how these two molecules interact in EOC cells. Additionally, in vivo mouse studies were performed to confirm the functional involvement of FOXM1 in EOC tumor formation and progression. We show for the first time that LPA up-regulates expression of active FOXM1 splice variants in a time-and dose-dependent manner in the human EOC cell lines OVCA433, CAOV3, and OVCAR5. Gi-PI3K-AKT and G12/13-Rho-YAP signaling pathways were both involved in the LPA receptor (LPA1-3) mediated up-regulation of FOXM1 at the transcriptional level. In addition, down-regulation of FOXM1 in CAOV3 xenografts significantly reduced tumor and ascites formation, metastasis, and expression of FOXM1 target genes involved in cell proliferation, migration, or invasion. Collectively, our data link the oncolipid LPA, the oncogene YAP, and the central regulator of cell proliferation/mutagenesis FOXM1 in EOC cells. Moreover, these results provide further support for the importance of these pathways as potential therapeutic targets in EOC.

Original languageEnglish (US)
Pages (from-to)27688-27699
Number of pages12
JournalOncotarget
Volume6
Issue number29
DOIs
StatePublished - 2015

Fingerprint

Ovarian Neoplasms
Up-Regulation
Lysophosphatidic Acid Receptors
Cell Proliferation
Gene Knockdown Techniques
Neoplasms
G-Protein-Coupled Receptors
RNA Interference
Phosphatidylinositol 3-Kinases
Oncogenes
Ascites
Heterografts
Mutagenesis
Genes
Cell Movement
Ovarian epithelial cancer
lysophosphatidic acid
Transcription Factors
Down-Regulation
Pharmacology

Keywords

  • EOC (epithelial ovarian cancer)
  • FOXM1
  • HGSC (high grade serous ovarian cancer)
  • LPA (lysophosphatidic acid)
  • YAP (yes-associated protein)

ASJC Scopus subject areas

  • Oncology

Cite this

FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer. / Fan, Qipeng; Cai, Qingchun; Xu, Yan.

In: Oncotarget, Vol. 6, No. 29, 2015, p. 27688-27699.

Research output: Contribution to journalArticle

@article{4b72643bf95d4b5da9ad292287153ec5,
title = "FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer",
abstract = "Lysophosphatidic acid (LPA), a prototypical ligand for G protein coupled receptors, and Forkhead box protein M1 (FOXM1), a transcription factor that regulates expression of a wide array of genes involved in cancer initiation and progression, are two important oncogenic signaling molecules in human epithelial ovarian cancers (EOC). We conducted in vitro mechanistic studies using pharmacological inhibitors, genetic forms of the signaling molecules, and RNAi-mediated gene knock-down to uncover the molecular mechanisms of how these two molecules interact in EOC cells. Additionally, in vivo mouse studies were performed to confirm the functional involvement of FOXM1 in EOC tumor formation and progression. We show for the first time that LPA up-regulates expression of active FOXM1 splice variants in a time-and dose-dependent manner in the human EOC cell lines OVCA433, CAOV3, and OVCAR5. Gi-PI3K-AKT and G12/13-Rho-YAP signaling pathways were both involved in the LPA receptor (LPA1-3) mediated up-regulation of FOXM1 at the transcriptional level. In addition, down-regulation of FOXM1 in CAOV3 xenografts significantly reduced tumor and ascites formation, metastasis, and expression of FOXM1 target genes involved in cell proliferation, migration, or invasion. Collectively, our data link the oncolipid LPA, the oncogene YAP, and the central regulator of cell proliferation/mutagenesis FOXM1 in EOC cells. Moreover, these results provide further support for the importance of these pathways as potential therapeutic targets in EOC.",
keywords = "EOC (epithelial ovarian cancer), FOXM1, HGSC (high grade serous ovarian cancer), LPA (lysophosphatidic acid), YAP (yes-associated protein)",
author = "Qipeng Fan and Qingchun Cai and Yan Xu",
year = "2015",
doi = "10.18632/oncotarget.4280",
language = "English (US)",
volume = "6",
pages = "27688--27699",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "29",

}

TY - JOUR

T1 - FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer

AU - Fan, Qipeng

AU - Cai, Qingchun

AU - Xu, Yan

PY - 2015

Y1 - 2015

N2 - Lysophosphatidic acid (LPA), a prototypical ligand for G protein coupled receptors, and Forkhead box protein M1 (FOXM1), a transcription factor that regulates expression of a wide array of genes involved in cancer initiation and progression, are two important oncogenic signaling molecules in human epithelial ovarian cancers (EOC). We conducted in vitro mechanistic studies using pharmacological inhibitors, genetic forms of the signaling molecules, and RNAi-mediated gene knock-down to uncover the molecular mechanisms of how these two molecules interact in EOC cells. Additionally, in vivo mouse studies were performed to confirm the functional involvement of FOXM1 in EOC tumor formation and progression. We show for the first time that LPA up-regulates expression of active FOXM1 splice variants in a time-and dose-dependent manner in the human EOC cell lines OVCA433, CAOV3, and OVCAR5. Gi-PI3K-AKT and G12/13-Rho-YAP signaling pathways were both involved in the LPA receptor (LPA1-3) mediated up-regulation of FOXM1 at the transcriptional level. In addition, down-regulation of FOXM1 in CAOV3 xenografts significantly reduced tumor and ascites formation, metastasis, and expression of FOXM1 target genes involved in cell proliferation, migration, or invasion. Collectively, our data link the oncolipid LPA, the oncogene YAP, and the central regulator of cell proliferation/mutagenesis FOXM1 in EOC cells. Moreover, these results provide further support for the importance of these pathways as potential therapeutic targets in EOC.

AB - Lysophosphatidic acid (LPA), a prototypical ligand for G protein coupled receptors, and Forkhead box protein M1 (FOXM1), a transcription factor that regulates expression of a wide array of genes involved in cancer initiation and progression, are two important oncogenic signaling molecules in human epithelial ovarian cancers (EOC). We conducted in vitro mechanistic studies using pharmacological inhibitors, genetic forms of the signaling molecules, and RNAi-mediated gene knock-down to uncover the molecular mechanisms of how these two molecules interact in EOC cells. Additionally, in vivo mouse studies were performed to confirm the functional involvement of FOXM1 in EOC tumor formation and progression. We show for the first time that LPA up-regulates expression of active FOXM1 splice variants in a time-and dose-dependent manner in the human EOC cell lines OVCA433, CAOV3, and OVCAR5. Gi-PI3K-AKT and G12/13-Rho-YAP signaling pathways were both involved in the LPA receptor (LPA1-3) mediated up-regulation of FOXM1 at the transcriptional level. In addition, down-regulation of FOXM1 in CAOV3 xenografts significantly reduced tumor and ascites formation, metastasis, and expression of FOXM1 target genes involved in cell proliferation, migration, or invasion. Collectively, our data link the oncolipid LPA, the oncogene YAP, and the central regulator of cell proliferation/mutagenesis FOXM1 in EOC cells. Moreover, these results provide further support for the importance of these pathways as potential therapeutic targets in EOC.

KW - EOC (epithelial ovarian cancer)

KW - FOXM1

KW - HGSC (high grade serous ovarian cancer)

KW - LPA (lysophosphatidic acid)

KW - YAP (yes-associated protein)

UR - http://www.scopus.com/inward/record.url?scp=84944453851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944453851&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.4280

DO - 10.18632/oncotarget.4280

M3 - Article

C2 - 26299613

AN - SCOPUS:84944453851

VL - 6

SP - 27688

EP - 27699

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 29

ER -